XIST, LINC00173, FBN1, COL1A1, COL5A1, and BGN were identified as key molecules in the network, which have potential diagnostic value and may be therapeutic targets for ARVC. Here, LINC00173 is linked to Arrhythmogenic right ventricular dysplasia.